Liquid pharmaceutical formulations for oral administration of a CGRP antagonist

Details for Australian Patent Application No. 2007293032 (hide)

Owner Merck & Co., Inc.

Inventors Breslin, David; Stellabott, Joyce; Alani, Laman L.; Jahansouz, Hossain; Thompson, Karen

Agent Spruson & Ferguson

Pub. Number AU-A-2007293032

PCT Pub. Number WO2008/030524

Priority 60/843,052 08.09.06 US

Filing date 6 September 2007

Wipo publication date 13 March 2008

International Classifications

A01N 43/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 9/66 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/030524 Priority application(s): WO2008/030524

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007293040-Substituted oxazole ketone modulators of fatty acid amide hydrolase

2007293028-Heterocyclic GPR40 modulators